A new study from China offers one of the most detailed pictures yet of what actually drives parents to vaccinate their daughters against human papillomavirus, the sexually transmitted virus responsible for the vast majority of cervical cancer cases worldwide. Using a rigorous survey technique known as a discrete choice experiment, researchers from Nanjing Medical University, working with collaborators in Australia and the United Kingdom, quantified how caregivers weigh vaccine attributes, service delivery models and incentive schemes when deciding whether to have an unvaccinated daughter aged 9 to 18 immunized. The findings, published in BMC Health Services Research, suggest that the most powerful levers for raising vaccine uptake are not price cuts but credible medical endorsement, school-based delivery, and appeals to community benefit.
The research team recruited 301 caregivers of unvaccinated adolescent girls through hospitals and community health service centers in Jiangsu and Zhejiang provinces, two economically developed eastern coastal regions of China. The median age of the caregivers surveyed was 41 years, with an interquartile range of 38 to 44, meaning the respondents were overwhelmingly mothers and fathers in the prime of their decision-making years for family health matters. Each participant completed two separate discrete choice experiments: one presenting hypothetical vaccine profiles varying in attributes such as cancer protection, side-effect risk and cost, and another presenting alternative vaccination service delivery arrangements varying in who recommends the vaccine, where it is administered, how appointments are made, and what incentives are offered.
Discrete choice experiments rest on a foundational principle of behavioral economics: people rarely judge a health intervention on a single attribute. Instead, they mentally trade off competing characteristics, accepting a higher out-of-pocket price in exchange for better protection, or tolerating a small risk of side effects if the expected benefit is large. By randomly varying attribute levels across repeated choice sets and analyzing responses with mixed logit models, researchers can estimate the relative weight each attribute carries in the decision and, critically, predict how uptake would shift under realistic policy scenarios. This approach moves beyond simple opinion surveys, which often overstate willingness to act, because respondents must make consequential trade-offs with every choice.
When it came to the vaccine itself, two attributes towered over all others. Protection against cervical cancer carried a relative importance of 25.2 percent, while the risk of severe side effects accounted for 21.3 percent of the decision weight. Protection against genital warts followed closely at 20.3 percent, an intriguing result because it suggests Chinese caregivers value a benefit that extends beyond cancer prevention to broader sexual health. Cost contributed 11.9 percent and place of manufacture 11.6 percent, with all five attributes showing statistically significant effects at the p less than 0.05 threshold. Notably, the country where a vaccine is manufactured, an attribute that has generated considerable public discussion in China amid the introduction of domestic HPV vaccines, mattered less than every clinical attribute, indicating that perceived efficacy and safety dominate the calculus.
The service delivery experiment revealed an equally instructive hierarchy. Who recommends the vaccine was by far the most influential factor, carrying a relative importance of 35.3 percent, more than any single vaccine attribute. Incentives ranked second at 19.5 percent, followed by vaccination location at 17.5 percent, message framing at 13.1 percent and appointment methods at 12.4 percent, all statistically significant. In practical terms, a recommendation from a doctor carried far more weight than a generic reminder message, and the promise of an incentive meaningfully shifted preferences, particularly when framed in altruistic terms. The dominance of professional recommendation underscores a persistent truth in immunization research: trusted clinical messengers remain the single most reliable bridge between vaccine availability and vaccine uptake.
The policy simulations embedded in the study translate these preference weights into concrete projections. Predicted vaccine uptake increased by 40.8 percent when protection against both cervical cancer and genital warts was raised to the 90 percent level, a figure that speaks directly to the growing portfolio of nine-valent HPV vaccines capable of preventing a wider spectrum of HPV-related disease. Even more striking, projected service uptake rose by 54.5 percent when three elements were combined: a doctor’s recommendation, school-based vaccination, and altruistic incentives that appeal to protecting others in the community rather than personal gain. This synergy effect is central to the paper’s conclusion, because no single intervention in isolation produced a comparable improvement.
The emphasis on altruistic framing aligns with a growing body of behavioral science showing that messages highlighting collective benefit can outperform self-interested appeals, particularly in cultural contexts that prize family and community obligation. In China, where HPV vaccination programs for adolescents are still expanding and coverage among the target 9 to 14 age group lags behind WHO elimination targets, such culturally resonant framing may prove decisive. The authors argue that integrating evidence-based vaccine education, culturally sensitive delivery models, and well-designed incentive structures could accelerate progress toward the World Health Organization’s 90-70-90 strategy, which calls for fully vaccinating 90 percent of girls by age 15 in every country by 2030.
Methodologically, the study strengthens a literature that has often relied on smaller samples or simpler survey designs. The dual-experiment architecture allowed the researchers to separate questions about the product itself from questions about how the product reaches families, a distinction that matters for policy because ministries of health control service delivery while vaccine attributes are fixed by manufacturers and regulators. Model fit was assessed using standard information criteria, and the mixed logit specification captured preference heterogeneity across respondents, acknowledging that a single average preference may mask meaningful variation between urban and rural families, between income groups, and between caregivers with different levels of health literacy. The study received ethical approval from Nanjing Medical University and was funded by the National Natural Science Foundation of China and institutional career development grants.
The limitations are worth noting. The sample was drawn from two relatively affluent eastern provinces, so preference weights may differ in less developed regions where cost sensitivity could be higher and access to physician recommendations scarcer. Discrete choice experiments measure stated preferences rather than revealed behavior, and the gap between what people say in a survey and what they do at a clinic is well documented. Still, the internal consistency of the findings, with the most clinically meaningful attributes and the most trusted messengers emerging as dominant drivers, provides a credible roadmap for program designers.
For global cervical cancer elimination efforts, the message from Nanjing is ultimately optimistic. Caregivers in this study were not immutable vaccine skeptics; they were rational decision-makers whose choices responded predictably to information, access and incentives. When vaccines offer broad protection, when doctors speak clearly and consistently in their favor, when clinics come to schools so that a vaccination does not require a parent to lose a day of work, and when public health campaigns appeal to the shared goal of a cancer-free generation, uptake responds. As China continues to scale its national immunization infrastructure and domestic vaccine supply, the study’s evidence-based playbook offers a template not only for China but for the many middle- and low-income countries now designing adolescent HPV vaccination programs from the ground up.
Beyond the headline findings, the study’s design details illuminate how preference research can inform immunization policy in practice. Because the two experiments were analyzed separately, the authors could quantify trade-offs within each domain without conflating how caregivers judge a vaccine’s clinical profile with how they judge the system that delivers it. This separation matters for implementation: regulators and manufacturers determine efficacy and safety profiles, while local health authorities control who delivers recommendations, where clinics operate, and which incentives are offered, so the service-side results point to actions that are immediately actionable by program managers.
The prominence of recommendation sources, at more than a third of the decision weight in the service experiment, echoes a consistent theme in vaccination research across countries: the credibility of the messenger often outweighs the content of the message. That incentives still contributed nearly a fifth of the weight suggests they are best understood as complements to, rather than substitutes for, clinical endorsement. Similarly, the moderate weight given to appointment methods implies that reducing logistical friction helps, but only at the margin once trust and access are established.
For readers interpreting the uptake projections, the combined-scenario gains should be viewed as upper-bound estimates grounded in stated choices. Nevertheless, the direction of the effects, with clinical benefit, professional endorsement, school delivery and altruistic framing all pulling in the same direction, offers a coherent, testable framework that future implementation studies in China and comparable settings can evaluate in real-world rollout.
Subject of Research: Caregiver preferences for HPV vaccination services and incentives for adolescent girls in China
Article Title: HPV vaccination services and incentives preferences of Chinese daughters’ caregivers: a discrete choice experiment
Article References: Fang, H., Li, Y., Yang, S., Li, M., Huang, B., Chow, E. P. F., Ong, J. J., Wu, D., & Zhang, Y. (2026). HPV vaccination services and incentives preferences of Chinese daughters’ caregivers: a discrete choice experiment. BMC Health Services Research. https://doi.org/10.1186/s12913-026-15397-y
Image Credits: AI Generated
DOI: 10.1186/s12913-026-15397-y
Keywords: HPV, vaccination, discrete choice experiment, parental preferences, cervical cancer, adolescent health, China, vaccine incentives, school-based vaccination, mixed logit model, health services research, services
Cite Scienmag News
APA
MLA
Chicago
Ophelia Keating. (September 12, 2026). Doctors, Schools and Altruism: What Makes Chinese Parents Say Yes to HPV Vaccines. Scienmag. https://scienmag.com/doctors-schools-and-altruism-what-makes-chinese-parents-say-yes-to-hpv-vaccines/
Ophelia Keating. “Doctors, Schools and Altruism: What Makes Chinese Parents Say Yes to HPV Vaccines.” Scienmag, 12 September 2026, https://scienmag.com/doctors-schools-and-altruism-what-makes-chinese-parents-say-yes-to-hpv-vaccines/. Accessed 12 September 2026.
Ophelia Keating. “Doctors, Schools and Altruism: What Makes Chinese Parents Say Yes to HPV Vaccines.” Scienmag. September 12, 2026. https://scienmag.com/doctors-schools-and-altruism-what-makes-chinese-parents-say-yes-to-hpv-vaccines/
Copy citation
Download RIS
Tags: adolescent healthcaregiver perspectives on HPV immunizationcervical cancercervical cancer prevention strategiesChinacommunity health and vaccinationdiscrete choice experimentdiscrete choice experiment in health behaviorfactors affecting HPV vaccine uptakehealth services researchhealthcare policy for vaccine deliveryHPVHPV vaccine decision-making in Chinaincentive schemes for vaccine acceptancemedical endorsement impact on vaccine acceptancemixed logit modelparental attitudes towards adolescent vaccinesparental influence on adolescent vaccinationparental preferencesschool-based vaccinationschool-based vaccine deliveryservicesvaccinationvaccine incentives
